| Bioactivity | XMU-MP-2 is a BRK inhibitor with significant inhibitory activity on BRK-positive cells. XMU-MP-2 inhibits oncogenic BRK-driven tumor growth in a mouse xenograft model. XMU-MP-2 also synergizes with HER2 inhibitors or endoplasmic reticulum (ER) blockade to exert antiproliferative activity[1]. |
| CAS | 2031152-10-8 |
| Formula | C32H33F3N8O2 |
| Molar Mass | 618.65 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jiang J, et al. Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors. Cancer Res. 2017 Jan 1;77(1):175-186. |
XMU-MP-2
CAS: 2031152-10-8 F: C32H33F3N8O2 W: 618.65
XMU-MP-2 is a BRK inhibitor with significant inhibitory activity on BRK-positive cells. XMU-MP-2 inhibits oncogenic BRK-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.